NCT06366750Phase 2Active not recruiting

A Study of Barzolvolimab in Patients With Prurigo Nodularis

Study sponsor: Celldex Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-03-17Actual
Enrollment · participants140Actual
Source updated2026-08-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jun 2026. After: 17 Mar 2026.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 120 participants (planned). After: 140 participants (actual).

Primary completion date changed

Before: Jan 2026. After: Jun 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source